| Biogen Licenses Sage’s GABAA Modulators to Bolster CNS Pipeline |
Abstract
pdf
html
|
|
Pratika Pahwa & Michelle Liu |
|
| Merck KGaA Strengthens Synthetic Lethality Pipeline with US$6.9 B Artios Alliance |
Abstract
pdf
html
|
|
Michelle Liu |
|
| Eli Lilly Continues Neuroscience Expansion with US$1.36 B Disarm Therapeutics Buy |
Abstract
pdf
html
|
|
Neha Madhwani & Michelle Liu |
|
| Gilead Makes Virology Bet with MYR Buy |
Abstract
pdf
html
|
|
Michelle Liu |
|
| AstraZeneca Bolsters Immunology Footprint with US$39 B Alexion Buyout |
Abstract
pdf
html
|
|
Michelle Liu, |
|
| Covis Group Acquires AMAG Pharmaceuticals for US$498 M |
Abstract
pdf
html
|
|
Sasha Yachu & Michelle Liu |
|
| Bayer Highlights Cell and Gene Therapy Commitment with US$4 B Asklepios Buyout |
Abstract
pdf
html
|
|
Ashish Tripathi & Michelle Liu |
|
